VISTA: A Promising Target for Cancer Immunotherapy?

VISTA: A Promising Target for Cancer Immunotherapy?

Marco Tagliamento,1,2 Elisa Agostinetto,3,4 Roberto Borea,2,5 Mariana Brandão,3 Francesca Poggio,6 Alfredo Addeo,7 Matteo Lambertini2,8 1Department of Medical Oncology, Medical Oncology 2, IRCCS Ospedale Policlinico San Martino, Genova, Italy; 2Department of Internal Medicine and Medical...

Full description

Bibliographic Details
Main Authors:	Tagliamento M, Agostinetto E, Borea R, Brandão M, Poggio F, Addeo A, Lambertini M
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-06-01
Series:	ImmunoTargets and Therapy
Subjects:	vista immune checkpoint inhibitor immunotherapy cancer biomarker
Online Access:	https://www.dovepress.com/vista-a-promising-target-for-cancer-immunotherapy-peer-reviewed-fulltext-article-ITT

Similar Items

VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy
by: Najibeh Shekari, et al.
Published: (2023-11-01)

IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
by: Xi-Yang Tang, et al.
Published: (2022-07-01)

Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights
by: Randolph J. Noelle, et al.
Published: (2023-09-01)

VISTA expression and patient selection for immune-based anticancer therapy
by: Alexander S. Martin, et al.
Published: (2023-02-01)

VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy
by: Xing Huang, et al.
Published: (2020-06-01)

The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead
by: Negar Hosseinkhani, et al.
Published: (2021-05-01)

Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
by: Dia Roy, et al.
Published: (2023-10-01)

Distinct immune stimulatory effects of anti-human VISTA antibodies are determined by Fc-receptor interaction
by: Sven Mostböck, et al.
Published: (2022-07-01)

Identification and optimization of peptide inhibitors to block VISTA/PSGL-1 interaction for cancer immunotherapy
by: Xiaoshuang Niu, et al.
Published: (2023-11-01)

The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma
by: Nour el Imane Issam Salah, et al.
Published: (2023-08-01)

Comprehensive Transcriptomic Analysis of VISTA in Acute Myeloid Leukemia: Insights into Its Prognostic Value
by: Simona Pagliuca, et al.
Published: (2022-11-01)

Enhancement of Radiation Therapy through Blockade of the Immune Checkpoint, V-domain Ig Suppressor of T Cell Activation (VISTA), in Melanoma and Adenocarcinoma Murine Models
by: Kayla E. A. Duval, et al.
Published: (2023-09-01)

VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes
by: Andreia Gameiro, et al.
Published: (2021-11-01)

Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia
by: Jianshan Mo, et al.
Published: (2023-02-01)

Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness
by: Thomas W. K. Broughton, et al.
Published: (2019-11-01)

VISTA in Soft Tissue Sarcomas: A Perspective for Immunotherapy?
by: Markus Albertsmeier, et al.
Published: (2022-02-01)

VISTA: A Target to Manage the Innate Cytokine Storm
by: Mohamed A. ElTanbouly, et al.
Published: (2021-02-01)

Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress
by: Matteo Perrino, et al.
Published: (2023-01-01)

A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors
by: Shawn Iadonato, et al.
Published: (2023-12-01)

Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer
by: Lucile Pabst, et al.
Published: (2023-04-01)

Corrigendum: A highly potent anti-VISTA antibody KVA12123 - a new immune checkpoint inhibitor and a promising therapy against poorly immunogenic tumors
by: Shawn Iadonato, et al.
Published: (2024-01-01)

VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses
by: Yusheng Lin, et al.
Published: (2024-03-01)

A Promising Treatment Strategy for Lung Cancer: A Combination of Radiotherapy and Immunotherapy
by: Yuhei Miyasaka, et al.
Published: (2021-12-01)

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
by: Shuang Qin, et al.
Published: (2019-11-01)

VISTA Blockade Aggravates Bone Loss in Experimental Murine Apical Periodontitis
by: Fuhua Yang, et al.
Published: (2021-10-01)

Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
by: Mai F. Tolba, et al.
Published: (2021-11-01)

Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging Prospects
by: Wanting Hou, et al.
Published: (2023-10-01)

Biomarkers of Response and Resistance to Immunotherapy in Microsatellite Stable Colorectal Cancer: Toward a New Personalized Medicine
by: Nicolas Huyghe, et al.
Published: (2022-04-01)

Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer
by: Flavia Jacobs, et al.
Published: (2023-05-01)

Immunotherapy in Metastatic Colorectal Cancer: Could the Latest Developments Hold the Key to Improving Patient Survival?
by: Emmanouil Damilakis, et al.
Published: (2020-04-01)

Liquid biopsy biomarkers to guide immunotherapy in breast cancer
by: Jinghan Yang, et al.
Published: (2023-11-01)

Predictive biomarkers of colon cancer immunotherapy: Present and future
by: Wanting Hou, et al.
Published: (2022-11-01)

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
by: Mengwei Zhang, et al.
Published: (2023-09-01)

Immunotherapy as a Promising Option for the Treatment of Advanced Chordoma: A Systemic Review
by: Xiang Wang, et al.
Published: (2022-12-01)

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
by: Junyu Long, et al.
Published: (2022-02-01)

Editorial: Immunotherapy and multimodality therapy for lung cancer
by: Chenghu Song, et al.
Published: (2024-01-01)

Research Progress of Efficacy Biomarkers Related to Immune Checkpoint Inhibitors
by: YANG Wenwen, et al.
Published: (2022-05-01)

Targeting Both Autophagy and Immunotherapy in Breast Cancer Treatment
by: Spyridon Giannopoulos, et al.
Published: (2022-10-01)

Editorial: Targeted Immunotherapy for Cancer
by: Williams V. Williams
Published: (2022-04-01)

The Cellular and Molecular Immunotherapy in Prostate Cancer
by: Anirban Goutam Mukherjee, et al.
Published: (2022-08-01)